Table 2.
Efficacy outcomes in patients treated with triptorelin for up to 24 weeks following conservative surgery for DIE.
| 12 months | 24 months | |||
| Outcomes | N | n (%) | N | n (%) |
| Cumulative improvement rate | ||||
| Pelvic pain | 223 | 162 (72.6) | 223 | 166 (74.4) |
| Dysmenorrhea | 323 | 269 (83.3) | 323 | 270 (83.6) |
| Pain at time of ovulation | 138 | 76 (55.1) | 138 | 76 (55.1) |
| Dyspareunia | 163 | 109 (66.9) | 163 | 109 (66.9) |
| Menorrhagia | 41 | 32 (78.0) | 41 | 32 (78.0) |
| Metrorrhagia | 37 | 22 (59.5) | 37 | 22 (59.5) |
| Gastrointestinal symptoms | 119 | 90 (75.6) | 119 | 90 (75.6) |
| Urinary symptoms | 29 | 17 (58.6) | 29 | 17 (58.6) |
| Cumulative recurrence rate | 320 | 41 (12.8) | 320 | 71 (22.2) |
| Pelvic pain | 320 | 10 (3.1) | 320 | 14 (4.4) |
| Dysmenorrhea | 320 | 32 (10.0) | 320 | 54 (16.9) |
| Pain at time of ovulation | 320 | 4 (1.3) | 320 | 6 (1.9) |
| Dyspareunia | 320 | 2 (0.6) | 320 | 4 (1.3) |
| Menorrhagia | 320 | 3 (0.9) | 320 | 5 (1.6) |
| Metrorrhagia | 320 | 0 (0) | 320 | 0 (0) |
| Gastrointestinal symptoms | 320 | 4 (1.3) | 320 | 10 (3.1) |
| Urinary symptoms | 320 | 0 (0.0) | 320 | 0 (0.0) |
| Pregnancy rate, study population | 384 | 42 (10.9) | 384 | 66 (17.2) |
| Pregnancy rate, previously infertile patients | 59 | 11 (18.6) | 59 | 16 (27.1) |
| Spontaneous pregnancy | 11 | 8 (72.7) | 16 | 10 (62.5) |
| Assistance fertility | 11 | 3 (27.3) | 16 | 6 (37.5) |